Selling in Jalan Raja Ashman Shah (Jalan Hospital)? Homes here sold for a median of RM2,519,000.
Free to list, about two minutes, and the buyers reading this page will see it.
Posts about Jalan Raja Ashman Shah (Jalan Hospital)
No posts about Jalan Raja Ashman Shah (Jalan Hospital) yet. Be the first to share what’s happening here.
Nearby areas in Ipoh Utara
Taman Suria (Sun Land Residence)
Pangsapuri Cherry
Prima Kepayang @ Fair Park
Taman Lim, Ipoh
Green Town Business Centre
The Anderson @ Ipoh
Taman Merdeka
Taman Wing Onn
Yik Foong Kompleks
Wisma Octagon
Kinta Riverfront Hotel Suites
Taman Sri Desa (Ipoh)
Jalan Raja Ashman Shah (Jalan Hospital)
PSF median price per sq ft · 12m its change over the past 12 months
Most-traded areas in this mukim, by number of recorded subsale transactions. See every area in Ipoh Utara
Market Snapshot
CommercialRM2,519,000
RM364 psfMedian transaction price
JALAN RAJA ASHMAN SHAH (JALAN HOSPITAL), Fair Park, Ipoh Utara, 30450, Kinta, Perak, Malaysia
Jalan Raja Ashman Shah (Jalan Hospital) in Kinta, Perak recorded 1 subsale transactions between 2021 and 2026, sized between 6,875 and 6,924 sqft, with a median price of RM2.52 million and a median price per square foot (PSF) of RM364.
This area consists exclusively of commercial properties, with no residential listings recorded.
Price remained flat, and PSF growth was PSF remained flat.
Most transactions involved 3 - 3 1/2 storey shop, with minimal variety in property types.
For price per square foot, the median is RM364, with most transactions between RM364 and RM364. The usual range is RM253.95 to RM473.95, showing that most units are priced quite close to each other. With an IQR of RM220.00 and MAD of RM0, the PSF demonstrates reasonable consistency across the market.
Overall, the market in this area appears stable with consistent appreciation, making it an attractive option for both investors and homebuyers. The consistent property type and stable pricing make it easier to assess value and compare trends. Limited transaction history suggests carefully evaluating comparable sales data.